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Abstract
Many of the molecular and cellular mechanisms discovered to regulate skeletal muscle hypertrophy were first identified using the rodent synergist ablation
model. This model reveals the intrinsic capability and necessary pathways of skeletal muscle growth in response to mechanical overload (MOV). Reminiscent of
the rapid cellular growth observed with cancer, we hypothesized that in response
to MOV, skeletal muscle would undergo metabolic programming to sustain increased demands to support hypertrophy. To test this hypothesis, we analyzed
the gene expression of specific metabolic pathways taken from transcriptomic
microarray data of a MOV time course. We found an upregulation of genes involved in the oxidative branch of the pentose phosphate pathways (PPP) and
mitochondrial branch of the folate cycle suggesting an increase in the production of NADPH. In addition, we sought to determine the potential role of skeletal
muscle-enriched microRNA (myomiRs) and satellite cells in the regulation of the
metabolic pathways that changed during MOV. We observed an inverse pattern
in gene expression between muscle-enriched myomiR-1 and its known target
gene glucose-6-phosphate dehydrogenase, G6pdx, suggesting myomiR regulation of PPP activation in response to MOV. Satellite cell fusion had a significant
but modest impact on PPP gene expression. These transcriptomic findings suggest the robust muscle hypertrophy induced by MOV requires enhanced redox
metabolism via PPP production of NADPH which is potentially regulated by a
myomiR network.
KEYWORDS
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I N T RO DU CT ION

First described almost 60 years ago, the rodent synergist
ablation model has been instrumental in identifying many
of the cellular and molecular mechanisms involved in the
regulation of skeletal muscle hypertrophy which were
subsequently shown to be conserved in humans in response to resistance exercise (Baar & Esser, 1999; Bodine
et al., 2001; DeVol et al., 1990; Goldberg et al., 1975;
Hornberger et al., 2006). In particular, synergist ablation
has been reported to increase mouse plantaris muscle
weight by 30%–50% following 14 days of MOV (Roberts
et al., 2020; Terena et al., 2017; Vechetti et al., 2019). The
supra-physiological growth induced by synergist ablation-
induced MOV reveals the remarkable intrinsic capability
of skeletal muscle to hypertrophy. The identification of the
metabolic processes that allow for such rapid and robust
hypertrophic growth may provide insight that can be used
to enhance the recovery of muscle following periods of
disuse or under conditions in which the growth response
to a hypertrophic stimulus is impaired such as with aging.
Metabolism has an essential role during cellular
growth, whereby multiple pathways generate and provide
the necessary requirements needed for anabolism (Zhu &
Thompson, 2019). However, despite this evidence, during
skeletal muscle hypertrophy the focus has primarily been
on mTOR signaling, energy systems that rapidly produced
ATP such as glycolysis and the phosphocreatine pathway, and the energy sensor AMPK (Egan & Zierath, 2013;
Hargreaves & Spriet, 2020; Kjobsted et al., 2018; Miyazaki
& Esser, 2009). The role of metabolic reprograming during
skeletal muscle growth has only recently been investigated. For example, it was demonstrated the participation
of important metabolic processes, such as the polyamine
pathway, hexosamine biosynthetic pathway, and serine
synthesis pathways play a role in skeletal muscle hypertrophy (Lambert et al., 2018; Stadhouders et al., 2020; Tabbaa
et al., 2021). Therefore, overlooked metabolic networks
may be contributing to the regulation of muscle mass.
MOV induces rapid and robust skeletal muscle growth
which resembles the accelerated growth that occurs in
cancer cells. It has been demonstrated that to be able to
handle the high rates of growth, cancer cells alter their
metabolism to rely more heavily upon the fermentation
of glucose to lactate despite the presence of oxygen and
functioning mitochondria (Hsu & Sabatini, 2008; Liberti
& Locasale, 2016; Sun et al., 2018; Warburg et al., 1927).
This metabolic phenomenon known as the Warburg Effect
(first described by Otto Warburg) was initially thought
to be critical for supplying ATP at a high rate necessary
to support the rapid cell growth associated with cancer
(Liberti & Locasale, 2016). This perspective has shifted in
recent years to one in which the main purpose of aerobic
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glycolysis (Warburg Effect) is not ATP production per se
but rather the generation of glycolytic intermediates that
serve as precursors for the macromolecules (e.g., nucleotides, amino acid, and lipids) required for cell growth
(Rosenzweig et al., 2018). In addition, metabolic reprograming could be a way in which redirecting metabolism
modulates metabolic intermediates that subsequently
dictates cellular behavior. This is seen in the control of
epigenetics (Diehl & Muir, 2020), transcription factors
(Li et al., 2018; Lu et al., 2002), enzymes (Maguire et al.,
2021), and increases in pathways which generate necessary substrates needed to fuel tumor growth (Fan et al.,
2019). Together, these results suggest that metabolic reprogramming can induce a variety of cellular changes
that could modify crucial signaling pathways related to
growth. Since MOV-induced skeletal muscle hypertrophy
stimulates a supra-physiological growth, we hypothesize
that, similarly to the cancer cells, skeletal muscle fibers
utilize aerobic glycolysis to support this rapid increase in
size.
As an initial effort to test this hypothesis, we analyzed
a microarray transcriptome time course analysis of MOV-
induced muscle hypertrophy and focused on genes specifically associated glucose metabolism. In support of our
hypothesis, we show the upregulation of genes known
to have a central role in the pentose phosphate pathway
(PPP) and one-
carbon metabolism for the production
of NADPH. We provide evidence for a role of muscle-
enriched myomiR-1 in the regulation of the PPP by targeting glucose-6-phosphate dehydrogenase, G6pdx, a known
target gene of myomiR-1, and the rate limiting step of the
PPP. Finally, we observed a modest response of PPP gene
expression upon satellite cell fusion, providing evidence
of the satellite-enriched myomiR-206 as an additional regulator of skeletal muscle metabolism during MOV. The
findings from our bioinformatics analyses identified candidate genes that warrant further investigation and their
respective role in the metabolic programming that permits
the robust hypertrophic growth induced by MOV.

2
2.1

|

METHODS

|

Animals

All experimental procedures involving mice were approved by the University of Kentucky Institutional
Animal Care and Use Committee. To deplete satellite
cells, we crossed Pax7CreER/CreER mouse (stock no. 017763)
to the Rosa26DTA/DTA mouse (stock no. 010527) (The
Jackson Laboratory) to generate the Pax7-DTA mouse
as previously described by us (Fry et al., 2014; McCarthy
et al., 2011; Murphy et al., 2011). Mice were housed in a
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temperature and humidity-
controlled room and maintained on a 14:10-h light-dark cycle with food and water
ad libitum.

2.2

|

Experimental design

Adult (5 months old) female Pax7-DTA mice were randomly assigned to receive either an intraperitoneal injection of tamoxifen (2.5 mg/day) or vehicle (15% ethanol in
sunflower seed oil) for five consecutive days followed by
a 2-week washout period. Following the washout period,
vehicle-and tamoxifen-treated mice were then randomly
assigned to sham or a synergist ablation surgery group
with the plantaris muscle collected after 1, 3, 5, or 7 days
(n = 5–6/group).

2.3

|

Synergist ablation

To induce skeletal muscle hypertrophy of plantaris muscle via mechanical overload (MOV), a bilateral synergist
ablation surgery which results in significant skeletal muscle hypertrophy, was performed as previously described
by our laboratory (Chaillou et al., 2013; Figueiredo et al.,
2019; Hamilton et al., 2014; McCarthy & Esser, 2007;
Vechetti et al., 2019). Mice were anesthetized (3% isoflurane with 1.5 L of O2 per minute), placed in sternal recumbence where a small incision was made on the dorsal
aspect of the lower hind limb with approximately half
of the gastrocnemius and entire soleus muscle carefully
excised. No apparent damage was observed to the neural
and vascular supply of the plantaris muscle following the
surgery. At the designated time point post-surgery, mice
were euthanized via CO2 inhalation followed by cervical
dislocation with the plantaris muscles excised, weighed,
snap frozen in liquid nitrogen, and stored at −80°C until
downstream analyses.

2.4

|

RNA isolation

Total RNA was isolated from plantaris muscle previously
frozen in liquid nitrogen. Samples were homogenized
using a tissue homogenizer (Bullet Blender, Next Advance
Inc.). Following homogenization, RNA was isolated via
phase separation by the addition of bromochloropropane (BCP) and centrifugation at 15,000 × g for 15 min.
The supernatant containing RNA was then washed with
the assistance of the Direct-zol™ Kit (Zymo Research).
RNA was treated in-column with DNAse and eluted in
nuclease-free water. The total RNA concentration and purity were assessed by measuring optical density (230, 260,
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and 280 nm) with a Nanodrop™ 2000/2000cSpectrophotometer (ThermoFisher Scientific).

2.5

|

Microarray dataset analysis

The microarray analysis was carried out with pooled samples as previously described by us (Chaillou et al., 2013).
Briefly, 250 ng of total RNA from a pool of 2 or 3 animals
(same amount of total RNA), resulting in n = 2 per group,
was used for each time point. The RNA was loaded onto
the GeneChip™ Mouse Gene 1.0 ST array (Affymetrix).
This microarray dataset is a part of another study by our
laboratory (currently in preparation for submission) and
has been deposited in the NCBI Gene Expression Omnibus
database (GSE15
3542). Microarray analysis focused
only on genes that are involved in metabolic pathways.
Bioinformatics analyses of the dataset were performed
in R (version 4.0.2) utilizing Bioconductor packages.
Briefly, raw signal intensity data were downloaded and
normalized with robust multi-array average (RMA) using
GEOquery (Davis & Meltzer, 2007) and oligo (Carvalho &
Irizarry, 2010) packages, respectively. Normalization consisted in background correction, quantile normalization,
and log2 transformation. For the detection of differentially
expressed genes (DEG) related to metabolic pathways,
we initially utilized microarray data from vehicle-treated
mice to determine changes associated with the rapid
growth induced by MOV. Having identified DEGs from
vehicle-treated mice, we then adjusted our statistical design to include microarray data from tamoxifen-treated
mice to determine if satellite cell depletion affected the
change in metabolic-related gene expression identified
in vehicle-treated mice in response to MOV. To identify
DEGs, a linear model was fitted to the normalized data
using Linear Models for Microarray Data (Limma) package (Ritchie et al., 2015). For vehicle-treated mice only
analysis, DEGs were estimated using the empirical Bayes
function with a false discovery rate (FDR) 5%, using the
Benjamini–Hochberg method. For comparison between
conditions (vehicle-treated vs. tamoxifen-treated), DEGs
were detected using a group-mean parametrization with
p < 0.05 due to the small sample size of n = 2 (pooled
samples).

2.6

|

MicroRNA expression

Reverse transcription reactions for myomiR-
206 and
U6 small nuclear RNA (Rnu6) were performed with
10 ng of total RNA using Taqman MicroRNA Reverse
Transcription Kit (ThermoFisher Scientific) according to
the manufacturer's directions. qPCR was carried out with
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Taqman Gene expression Master Mix (2×) (ThermoFisher
Scientific), TaqMan gene expression assay (miR-
206,
#000510; Rnu6, #001973) using cDNA in a 10 µl reaction
volume. qPCR was performed using the QuantStudio3
(Applied Biosystems) qPCR system as described by the
manufacturer. qPCR efficiency was calculated by linear
regression during the exponential phase using LinRegPCR
software v11.126 (Ruijter et al., 2009). The comparison of
miRNAs expression between groups was determined following normalization with Rnu6. Relative quantification
of miRNA expression was assessed by the ΔΔCT method
relative to the control.

2.7 | In silico prediction of miRNA
target genes
Target genes were detected using miRanda (Enright et al.,
2003) and RNAhybrid (Kruger & Rehmsmeier, 2006)
software. Since individual tools use different features for
miRNA:target interactions, we utilized a custom Python
script to select only shared miRNA:target gene between
the two software programs with a minimal free energy set
as ΔG°= −18 kJ.

|

2.8

Statistical analysis

The data are presented as means ± standard error. Except
for transcriptomic data (statistical analyses discussed
above), two-way ANOVA with Tukey post hoc analysis
was used to test the effect of genotype and intervention
on microRNA levels. Statistical analysis was performed
with GraphPad Prism version 9.2.0 (GraphPad Software).
Statistical significance was set at p < 0.05.

3
3.1

|

R E S U LTS

|

Glycolytic pathway

To determine if aerobic glycolysis might be involved in
providing the precursors for the macromolecules necessary for the growth induced by MOV, we analyzed a
microarray time course of MOV-induced muscle hypertrophy for genes known to be involved in metabolic pathways (Figure S1). Starting with glycolysis, we observed
higher levels of genes involved with glucose uptake and
intracellular phosphorylation (Glut1 and Hk2, respectively) in response to MOV (Figure 1). Glut1 expression
was higher throughout the time course, returning to baseline by day 7, whereas Hk2 level was elevated on days 1
and 3 but lower on days 5 and 7 of MOV. Downstream of
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Hk2, the level of the remaining genes involved in the glycolytic pathway was either unchanged (Gapdh or Aldoa) or
lower (Gpi, Pfkm, Pgk1, Pgam2, Pkm, and Eno3) at one or
more time points during MOV (Figure 1). The change in
the levels of glycolytic genes suggested that glucose were
being diverted to adjacent central carbon pathways.

3.2

|

Pentose phosphate pathway (PPP)

To determine if the PPP was activated during MOV-
induced muscle hypertrophy, we analyzed genes of both
the oxidative and the non-oxidative branches of the PPP.
In the oxidative branch, the rate limiting enzyme G6pdx
gene level was higher throughout the time course with
the downstream genes Pgls and Pgd elevated on day 7
and days 1 and 3 of MOV, respectively (Figure 2). For the
non-oxidative branch, the gene level of Rpe and Rpia was
not significantly different from sham whereas Tkt and
Taldo1 were higher on days 3 and 5 of MOV (Figure 2).
The increase in expression of G6pdx could lead to a subsequent increase in NADPH production. NADPH is the
reduced form of NADP+, therefore we sought to determine if Nadk1 (the kinase that phosphorylates NAD+),
could concomitantly increase as well; possibly as a means
to provide more substrate for G6pdx. We determined that
the expression of Nadk1 was higher on days 1 and 3 of
MOV (Figure 2).

3.3
3.3.1

|

One-carbon metabolism

|

Serine synthesis pathway (SSP)

The higher level of the genes associated with the oxidative
branch of the PPP and Nadk1 suggested the production
of NADPH was enhanced rather than de novo nucleotide
synthesis in response to MOV. This finding motivated us
to investigate if the levels of one-carbon metabolism genes
involved in NADPH production and nucleotide synthesis
(Newman & Maddocks, 2017) were also higher during
MOV. We first looked at the serine synthesis pathway
(SSP), as serine is used to generate the folate intermediate 5,10-methylenetetrahydrofolate, which participates in
the production nucleotides and NADPH (Geeraerts et al.,
2021). We observed the level of serine synthesis pathway
(SSP) genes which feeds serine into the folate cycle to generate NADPH, was altered with MOV. As shown in Figure
3, the lack of a pattern in the expression of SSP genes
Phdgh, Psat1, and Psph, suggested the de novo synthesis
of serine was not elevated in response to MOV. However,
level of the sodium-coupled neutral amino acid transporter, Slc38a1, was higher on days 3, 5, and 7 of MOV

VALENTINO et al.
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F I G U R E 1 Glucose uptake does not drive glycolysis during the rapid growth induced by mechanical overload (MOV). The glycolytic
pathway is not utilized during MOV as demonstrated by the log twofold change (blue: upregulated, red: downregulated and black: not
differentially expressed) in expression of the genes involved in glycolysis. N = 2/group (pooled samples). *denotes statistical significance
(adjusted p value <0.05) compared to sham (control)

suggesting extracellular serine could be the source needed
for downstream central carbon pathways (Figure 3).

3.3.2

|

The folate cycle

The folate cycle is compartmentalized in the cytosol and
mitochondria in which parallel reactions support one-
carbon anabolic pathways (Ducker & Rabinowitz, 2017).
The level of cytosolic Mthfd1 gene was lower throughout

the time course suggesting the cytosolic compartment
of the folate cycle was not participating in NADPH production during MOV (Figure 3). In contrast, the level of
mitochondrial Mthfd2 gene was highly elevated on days
1 and 3 of MOV suggesting high levels of NADPH could
be produced via the mitochondrial folate cycle (Figure 3).
Furthermore, we found that the gene which encodes for
a mitochondrial serine transporter, Sfnx1, was higher on
days 3, 5, and 7 of MOV. This supports the elevation in
Slc38a1 which could bring extracellular serine into the
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F I G U R E 2 Pentose Phosphate Pathway (PPP) is diverted from glycolysis during mechanical overload (MOV). PPP and Redox
metabolism are upregulated during MOV as highlighted by log twofold change (blue: upregulated and black: not differentially expressed) of
genes involved in these reactions. N = 2/group (pooled samples). *denotes statistical significance (adjusted p value <0.05) compared to sham
(control)

cell which further gets pumped into the mitochondria for
utilization of the folate pathway.
In terms of pathways related to reductive biosynthesis,
we did not observe any significant change in the levels of
genes involved in either fatty acid or amino acid synthesis,

suggesting that these pathways were not altered at the
transcript level in response to MOV (Figure S1). For nucleotide synthesis, the lack of a consistent pattern in the
gene expression in the non-oxidative branch of the PPP,
made it difficult to determine if there was a change in de
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F I G U R E 3 Serine and the folate cycle contribute additional NADPH during MOV: Serine may be generated via the serine synthesis
pathway or brought into the cell by the sodium-coupled neutral amino acids transporter (Slc38a1). Serine can then participate in the
generation of NADPH though the folate cycle. The mitochondrial compartment of the folate cycle is upregulated during MOV as highlighted
by log twofold change (blue: upregulated and black: not differentially expressed) of genes involved in these reactions. N = 2/group (pooled
samples). *denotes statistical significance (adjusted p value <0.05) compared to sham (control)

novo nucleotide synthesis. However, there was higher levels of genes (Aprt, Nme, and Hprt) of the purine salvage
pathway across the MOV time course (Figure S2), suggesting the participation of the folate cycle in purine synthesis. Additionally, Cmpk1, Rrm2, Ctps, Tyms, and Uck1
were elevated at some time point during MOV (Figure S3).
Finally, the elevated level of the neutral amino acid transporter Slc38a10 on days 3, 5, and 7 of MOV may enhance
pyrimidine synthesis by increasing intracellular glutamine and aspartate levels (Figure S3).

3.4

|

Redox metabolism

The elevated levels of genes of both the oxidative branch
of the PPP and the mitochondrial folate cycle suggested
higher NADPH synthesis in response to MOV. NADPH is
used in redox homeostasis and reductive biosynthesis to
produce fatty acids, amino acids, and nucleotides. NADPH
plays a major role in cellular redox homeostasis by combating oxidative stress through reducing glutathione, thioredoxins, and peroxiredoxins. In response to MOV, Gsr, and
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Gpx1, which encode the two enzymes directly involved in
glutathione reduction and oxidation, respectively, showed
higher levels and suggest redox homeostasis was likely the
primary process consuming NADPH (Figure 4). In addition, genes for thioredoxins and peroxiredoxins (Txnrd1
and Prdx 1, respectively) involved in other redox pathways
which can utilize NADPH to control hydrogen peroxide
(H2O2) (Netto & Antunes, 2016) were also highly elevated
during MOV (Figure 4).

3.5 | Potential regulation of metabolic
genes by myomiR-1 during MOV
MyomiR-1 is the most abundant miRNA in the mouse
plantaris muscle and shows the greatest change in
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expression in response to MOV of any miRNA (Vechetti
et al., 2021). To determine if the higher levels of PPP and
redox-related genes might be attributed to a decrease in
myomiR-1 expression, we performed a myomiR-1 target
gene prediction analysis on all of the significantly upregulated genes across the MOV time course. This analysis
identified a small set of genes involved in the PPP, SSP,
and redox homeostasis with predicted myomiR-1 seed
sequences within their respective 3'-UTR (Figure 5a). In
particular, genes of the oxidative (G6pdx and Pgd) and
non-oxidative (Tkt) branch of the PPP, SSP (Psat1), and
redox homeostasis (Gsr and Gclc). Together, these results
indicate a possible role of myomiR-1 in the regulation of
skeletal muscle metabolism by targeting key genes that
act synergistically to produce and utilize NADPH during
MOV.

F I G U R E 4 Redox metabolism
is increased during MOV. Pathways
related to the oxidation and reduction
of glutathione are upregulated during
MOV. In addition, other pathways that
utilize NADPH to scavenge hydrogen
peroxide increase during the first week
of MOV as highlighted by log twofold
change (blue: upregulated and black: not
differentially expressed) of genes involved
in these reactions. N = 2/group (pooled
samples). *denotes statistical significance
(adjusted p value <0.05) compared to
sham (control)

VALENTINO et al.
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F I G U R E 5 Skeletal muscle metabolism regulated by a myomiR-1 network. (a) In-silico prediction of myomiR-1 metabolic target genes
3’ UTR seed sequence and miyomiR-1 (b) Expression of G6pdx in SC+ and SC-skeletal muscle throughout the time course (c) G6pdx 3'-UTR
seed sequence and myomiR-206 (d) myomiR expression throughout the time course. Log twofold change of DEGs between Vehicle-and
Tamoxifen-treated mice after mechanical overload. N = 2/group (pooled samples) for (a-c), and n = 6 for (d). *denotes statistical significance
(p value <0.05) between vehicle-and tamoxifen-treated mice

3.6 | Influence of satellite cells on
metabolism during MOV
We next wanted to determine if satellite cell fusion might
be affecting the expression of PPP and redox homeostasis-
related genes. We compared plantaris muscle gene expression of vehicle-treated, satellite cell-replete (SC+), and
tamoxifen-treated, satellite cell-depleted (SC-) to identify
differentially expressed key metabolic genes across the
MOV time course (Figure S4). Specifically, this analysis

found that SC-G6pdx level was significantly higher on
days 5 and 7 of MOV compared to SC+; in particular,
SC- G6pdx level remained elevated while SC+G6pdx level
was returning towards baseline on days 5 and 7 of MOV
(Figure 5b).
Given that myomiR-206 has been previously shown
to be enriched in satellite cells (Fry et al., 2017), we hypothesized that the expression of myomiR-206, which is
known to target many of the same genes as myomiR-1
given their identical seed sequence (Figure 5c), would be
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higher in SC+compared to SC-and, as a result, repress
expression of these genes upon satellite fusion starting
at day 5 of MOV. In Figure 5d, qPCR analysis confirmed
miR-206 expression was higher at days 5 and 7 of MOV
in the SC+group whereas miR-206 expression did not
change across the MOV time course in SC-group, consistent with satellite cell proliferation and depletion,
respectively.

4

|

DI S C USSION

We identified a potential mechanism which could facilitate the rapid growth response observed in MOV-induced
skeletal muscle hypertrophy. Specifically, we identified
the pentose phosphate pathway (PPP) as a possible shunt
for glucose and highlighted the importance of the rate limiting enzyme of the PPP, G6pdx, in the regulation of skeletal muscle metabolism during hypertrophy. In response
to MOV, the results suggest the PPP becomes activated
which leads to an increase in NADPH that is subsequently
used in nucleotide biosynthesis and oxidative stress. We
also provide evidence for a potential mechanism involving
myomiRs modulating the expression of genes involved in
the metabolic reprograming induced by MOV.
It is well established that the PPP is essential for reductive biosynthesis and generation of NADPH (Vander
Heiden et al., 2009). Pharmacological inhibition of G6pdx
reduced nucleotide synthesis and tumor cell proliferation
in both pancreatic adenocarcinoma cells and mice hosting Ehrlich's ascitic tumor cells (Boros et al., 1997). In
contrast, overexpression of G6pdx was shown to increase
the levels of NADPH resulting in a higher rate of cellular growth under oxidative stress (Tian et al., 1998). While
these studies were not conducted in skeletal muscle, they
support a critical role of G6pdx in cell growth. The importance of the PPP in skeletal muscle adaptation has been
recently described by Hoshino and colleagues whereby
electrical stimulation of C2C12 myotubes led to an increase in reactive oxygen species-dependent activation of
the PPP (Hoshino et al., 2020). The reliance on the PPP for
muscle growth is also supported by studies investigating
the rapid muscle growth of broiler chickens and in mice
upon inducible, muscle-specific Akt-activation (Abasht
et al., 2016; Brothers et al., 2019). Finally, Wagner and colleagues found increased levels of G6pdx and Pgd in mice
after Marcaine-induced muscle damage indicating that
the PPP is upregulated to assist in the recovery from muscle damage (Wagner et al., 1978). Together, these studies,
along with the results of the current study, suggest that the
PPP is responsive to various stimuli and highlights the potentially important role of this pathway in skeletal muscle
hypertrophy and regeneration.
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The PPP is not the only pathway which can generate
NADPH, the folate and TCA cycles, malic enzymes, and
nicotinamide nucleotide transhydrogenase mitochondrial inner membrane proteins can all generate NADPH
(Ju et al., 2020). However, a previous study reported that
in growing cells the PPP and folate cycle are the primary
pathways responsible for NADPH production (Fan et al.,
2014), which agrees with our transcriptomic data. In particular, the transcriptomic data provides evidence that the
mitochondrial branch of the folate cycle, compared to
the cytosolic branch, could generate additional NADPH
during MOV (Figure 4). Ducker and co-workers propose
that the compartmentalization of the folate cycle is necessary in order to uncouple one-carbon metabolism from
glycolysis in an effort to preserve NAD+ and allow for the
continuation of glycolysis (Ducker & Rabinowitz, 2017).
Most recently Zhu and co-workers determined that mitochondrial NADPH production was essential for the
biosynthesis of proline, which contributed to collagen formation (Zhu et al., 2021). Therefore, these findings indicate that compartmentalizing NADPH synthesis could be
a strategy by which the spatial production of a metabolic
product ensures specific utilization.
It is well established that NADPH can be used to reduce oxidative stress with aberrant levels of NADPH associated with cancer, cardiovascular disease, and aging (Ju
et al., 2020; Xiao et al., 2018; Ying, 2008). In skeletal muscle, it has been demonstrated that muscle contractions can
increase both NADPH and ROS production (Henriquez-
Olguin et al., 2019; Hoshino et al., 2020). Interestingly,
increased levels of ROS can hydroxylate guanines of mRNA
(Kasai et al., 1991; Shan et al., 2007), decreasing translational fidelity, causing ribosomal stalling and shortened
peptides (Shan et al., 2007; Simms et al., 2014; Tanaka
et al., 2007). Furthermore, oxidative modifications can
occur on ribosomal proteins and ribosome modifying enzymes which may interfere with translation (Shcherbik
& Pestov, 2019). NADPH production could also attenuate
errors in protein synthesis by reducing the abundance of free
radicals that would otherwise cause expression of genes
associated with DNA damage, oxidized mRNA, and proteolysis (Song et al., 2021). Altogether, increasing NADPH
to reduce oxidative stress could allow for the high rate of
protein synthesis that occurs during MOV and suggests
that modulating NADPH could lead to improvements in
protein synthesis.
Metabolic pathways are complex and regulated at several levels with microRNAs shown to be involved in the
regulation of glycolysis and the PPP (Singh et al., 2013; Xu
et al., 2017). In addition, we and others have previously
demonstrated that microRNAs play a role in skeletal muscle plasticity (Bonanno et al., 2020; Hudson et al., 2014;
Kovanda et al., 2018; McCarthy & Esser, 2007; Silva et al.,
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2019). For example, myomiR-1, one of the most abundant
microRNAs in skeletal muscle, decreases during skeletal
muscle hypertrophy, suggesting this microRNA acts as a
repressor of growth (Chaillou et al., 2013; McCarthy &
Esser, 2007; Vechetti et al., 2021). Interestingly, myomiR-1
has also been shown to repress the activity of G6pdx resulting in an inhibitory effect on the PPP (Singh et al.,
2013). Our results propose that the rapid downregulation
of myomiR-1 in response to MOV leads to enhanced levels of G6pdx which, in turn, activates the PPP to generate
NADPH. The concomitant increase in the levels of G6pdx
with the decrease in myomiR-1 may be the impetus for the
metabolic shift observed during MOV.
It is well established that during MOV-induced muscle hypertrophy, satellite cells fuse to the muscle fibers,
contributing to the increase in myonuclei and potentially playing other hypertrophic supporting roles (Fry
et al., 2014; Kirby et al., 2016; Snijders et al., 2015). In
order to determine if satellite cell fusion affects the levels of G6pdx, during MOV-induced muscle hypertrophy,
we queried a microarray comparing the metabolic genes
between SC+ and SC-mice. We found that G6pdx was
significantly elevated in SC-when compared to SC+mice
(Figure 5b). Previous results from our laboratory supported a mechanism in which the delivery of satellite
cell-enriched myomiR-206-induced collagen remodeling
during MOV (Fry et al., 2017). In addition, myomiR-206
has also been shown to regulate G6pdx in both C2C12
myoblasts and cancer cells (Jiang et al., 2019; Singh et al.,
2013) as it shares a near identical seed region with myomiR-1. The results from the current study demonstrate
that myomiR-206 expression is significantly elevated at
days 5 and 7 of MOV only in SC+mice (Figure 5d) which
coincided with the lower G6pdx expression in SC-muscle
(Figure 5b). Together, these results suggest that satellite
cell-enriched myomiR-206 also participates in the metabolic reprograming during MOV-
induced muscle hypertrophy by modulating the levels of G6pdx. Although
our results are based on changes in gene expression and
microRNA target prediction, the regulation of G6pdx expression by myomiRs has been validated in cancer and
nonneoplastic fibroblast cells (Singh et al., 2013), where
an inverse correlation between myomiR-1, −206 and PPP
gene expression was demonstrated. Thus, we propose that
myomiR-1 and myomiR-206 contribute to the metabolic
reprograming that allows for the robust skeletal muscle
growth observed in response to MOV by activating the
PPP and one-carbon pathways.
The current study is not without limitations. The results rely exclusively on transcriptomic data to infer
changes in metabolic pathways in response to MOV. A
major focus of a future study will be to confirm the observed changes in gene expression are reflected at the
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protein level. Previous studies have reported that changes
in metabolic gene transcript levels correspond to similar
changes at the protein level (Gupte et al., 2011; Hoshino
et al., 2020; Singh et al., 2013; Weyrauch et al., 2020). In
addition, Weyrauch and colleagues, using the same hypertrophy model (i.e., MOV induced by synergist ablation) as used in the current study, showed that GLUT1
and G6PDH protein abundance as well as NADPH levels
were all higher in response to 5 days of MOV (Weyrauch
et al., 2020). This gives us confidence that the changes
in gene expression observed here are also physiological
meaningful. Additionally, samples were pooled for microarray analysis which limits the amount of biological
variation in our results. This may limit the extent to which
our results may be interpreted. Nonetheless, our results
still provide novel data regarding metabolic networks
that appear to be important for skeletal muscle growth
and are not diminished by the methodology. For example,
Mendias and co-workers performed a microarray analysis on rat plantaris muscle after 3, 7, and 28s of synergist
ablation (Mendias et al., 2017). RNA for this analysis was
not pooled allowing for each sample (n = 4 per group) to
be sequenced individually (Mendias et al., 2017). In line
with our results, G6pdx was significantly higher on day
3 compared to control (GSE62388), demonstrating consistencies among microarray analysis strategies. Another
potential limitation of the study is the fact that our transcriptomic analysis encompasses the whole muscle and
cannot distinguish the contribution of non-muscle cell
types to the observed changes in gene expression. For instance, macrophage abundance has been shown be significantly elevated after 5 days of MOV which may have
influenced the transcriptomic data given that macrophages undergo metabolic reprograming upon activation
(Novak et al., 2009; O'Neill et al., 2016). This concern is
tempered by the finding of Kirby and colleagues showing
that approximately 90% of nascent RNA is associated with
myonuclei during MOV induced by synergist ablation
(Kirby et al., 2016), thus providing confidence that most
of the observed changes in gene expression reflect what is
occurring within muscle fibers.
In conclusion, we provide evidence to suggest the robust muscle growth induced by MOV may rely upon metabolic reprogramming that involves activation of the PPP
and one-
carbon metabolic pathway. Further, our data
along with studies in cancer, indicate activation of the PPP
is regulated by myomiR targeting of G6pdx (Coda et al.,
2015; Singh et al., 2013). The findings from this study provide the foundation for future studies focused on determining the role of G6pdx in skeletal muscle hypertrophy.
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